Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
2,425,471
-
Share change
-
-260,854
-
Total reported value
-
$2,468,000
-
Price per share
-
$1.03
-
Number of holders
-
9
-
Value change
-
-$371,144
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2017
As of 31 Mar 2017 Aptose Biosciences Inc. - Common Shares had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,425,471 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, ROYAL BANK OF CANADA, BANK OF MONTREAL /CAN/, RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC, Federation des caisses Desjardins du Quebec, Parallax Volatility Advisers, L.P., MORGAN STANLEY, and Creative Planning.
This table shows 10 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.